Seed Newsvine
This once-hot cancer-detection company’s stock got cut in half after a
failed trial
-
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of
its Galleri early-detection cancer test failed to meet its primary endpoint.
23 minutes ago
No comments:
Post a Comment